@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP599422.RAVDpyxUqX4ppIKW1NdRgzDmj5MkFkyWjTdZdb8O2TFOo130_head { this: np:hasAssertion dgn-np:NP599422.RAVDpyxUqX4ppIKW1NdRgzDmj5MkFkyWjTdZdb8O2TFOo130_assertion; np:hasProvenance dgn-np:NP599422.RAVDpyxUqX4ppIKW1NdRgzDmj5MkFkyWjTdZdb8O2TFOo130_provenance; np:hasPublicationInfo dgn-np:NP599422.RAVDpyxUqX4ppIKW1NdRgzDmj5MkFkyWjTdZdb8O2TFOo130_publicationInfo; a np:Nanopublication . dgn-np:NP599422.RAVDpyxUqX4ppIKW1NdRgzDmj5MkFkyWjTdZdb8O2TFOo130_assertion a np:Assertion . dgn-np:NP599422.RAVDpyxUqX4ppIKW1NdRgzDmj5MkFkyWjTdZdb8O2TFOo130_provenance a np:Provenance . dgn-np:NP599422.RAVDpyxUqX4ppIKW1NdRgzDmj5MkFkyWjTdZdb8O2TFOo130_publicationInfo a np:PublicationInfo . } dgn-np:NP599422.RAVDpyxUqX4ppIKW1NdRgzDmj5MkFkyWjTdZdb8O2TFOo130_assertion { miriam-gene:4907 a ncit:C16612 . lld:C0155552 a ncit:C7057 . dgn-gda:DGNe95729504703da855be69ed8a8f4186a sio:SIO_000628 miriam-gene:4907, lld:C0155552; a sio:SIO_001121 . } dgn-np:NP599422.RAVDpyxUqX4ppIKW1NdRgzDmj5MkFkyWjTdZdb8O2TFOo130_provenance { dgn-np:NP599422.RAVDpyxUqX4ppIKW1NdRgzDmj5MkFkyWjTdZdb8O2TFOo130_assertion dcterms:description "[This prospective study involved 79 homozygote and heterozygote sickle cell anaemia patients (16 to 50 years old) and a control group of 40 people.All patients underwent ENT, audiological and brainstem auditory evoked responses (BSER) examinations in order to evaluate the incidence of sensorineural hearing loss (SNHL), to identify the changes at the level of the cochlear nerve and the central pathways, and to determine the most vulnerable group, in order to intervene with early prevention and rehabilitation for this condition.A hearing loss of greater than 20 dB at two or more frequencies was found in 36 (45.57 per cent) sickle cell patients (19 (47.22 per cent) HbSC patients and 17 (43.59 per cent) HbSS patients) and three (7.5 per cent) members of the control group.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:16762092; prov:wasDerivedFrom dgn-void:befree-20150227; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20150227 pav:importedOn "2015-02-27"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP599422.RAVDpyxUqX4ppIKW1NdRgzDmj5MkFkyWjTdZdb8O2TFOo130_publicationInfo { this: dcterms:created "2015-08-25T14:43:38+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v3.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v3.0.0" . }